Gastrointestinal and Cardiovascular Safety of Meloxicam

Gastrointestinal Safety

• The risk of gastrointestinal toxicity with non-selective NSAIDs correlates with their anti-inflammatory activity, making drugs with high analgesic effect at doses with low anti-inflammatory activity (like meloxicam) less ulcerogenic 1

Comparative Efficacy

• The American College of Gastroenterology notes that while ibuprofen may be preferred for temporary painful conditions due to its favorable safety profile at low doses, drugs with stronger anti-inflammatory properties (which would include meloxicam) may be more suitable for inflammatory conditions 1, 2

Common Pitfalls to Avoid

• Adding low-dose aspirin to any NSAID therapy (including meloxicam) increases the risk of gastrointestinal complications 3, 4
• Poor compliance with gastroprotective agents when prescribed alongside NSAIDs can increase the risk of upper GI adverse events 4-6 times 4